GRAL – grail, inc. (US:NASDAQ)
Stock Stats
News
GRAIL to Participate in Upcoming Investor Conferences
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
Grail, Inc. (NASDAQ: GRAL) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
GRAIL Reports Third Quarter 2024 Financial Results
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.